SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-124862
Filing Date
2018-04-20
Accepted
2018-04-20 16:05:57
Documents
5
Period of Report
2018-06-01
Effectiveness Date
2018-04-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A d557297ddef14a.htm DEF 14A 575981
2 GRAPHIC g557297g62b24.jpg GRAPHIC 90468
3 GRAPHIC g557297g80a55.jpg GRAPHIC 52118
4 GRAPHIC g557297pc1.jpg GRAPHIC 367994
5 GRAPHIC g557297pc2.jpg GRAPHIC 304237
  Complete submission text file 0001193125-18-124862.txt   1697133
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35670 | Film No.: 18766709
SIC: 2834 Pharmaceutical Preparations